Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1
- PMID: 2649255
- DOI: 10.1016/0008-8749(89)90254-2
Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1
Abstract
Mycobacterium avium-intracellulare (MAI) is a ubiquitous soil contaminant that rarely causes disseminated disease in adults regardless of immunological status. In AIDS patients, however, this organism invades virtually every tissue and organ, and most conventional chemotherapeutic agents are usually ineffective against MAI. We report here that monocytes, in which MAI has established an intracellular parasitic stage, are under the control of natural killer (NK) cells. Autologous large granular lymphocytes (LGL), purified from human peripheral blood leukocytes, were capable of efficiently lysing autologous MAI-infected monocytes in a 5-hr 51Cr release assay. More importantly, interleukin 2 (IL-2) was able to activate the LGL to a higher degree of lysis of infected monocytes. LGL cultured in medium alone could not kill normal monocytes, but showed some degree of lysis of MAI-infected cells. IL-2 activated killer (LAK) cells, on the other hand, lysed normal monocytes to a moderate degree and this activity was makedly enhanced if the monocytes were infected with MAI. The sensitivity of monocytes was directly proportional to the inoculating number of bacteria, indicating that increased bacterial burden would enhance susceptibility to LAK-mediated lysis. Finally, the addition of monoclonal antibodies to LFA-1 (both alpha and beta chains), but not LFA-2 or LFA-3, blocked lysis of both infected and uninfected monocytes when added directly to the cytotoxicity assays, indicating that this adhesion protein is involved in the lysis of autologous, infected monocytes. Thus, NK/LAK cells may be important in containment of infection by lysis of infected monocytes before the bacteria can multiply and spread to other sites.
Similar articles
-
Cytokine activation of killer cells in mycobacterial immunity.Adv Exp Med Biol. 1992;319:105-12. doi: 10.1007/978-1-4615-3434-1_12. Adv Exp Med Biol. 1992. PMID: 1414586
-
Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes.J Clin Immunol. 1990 Jan;10(1):71-7. doi: 10.1007/BF00917500. J Clin Immunol. 1990. PMID: 2312668
-
Lysis of human monocytes by lymphokine-activated killer cells.Cell Immunol. 1988 Jan;111(1):55-65. doi: 10.1016/0008-8749(88)90050-0. Cell Immunol. 1988. PMID: 2827894
-
Involvement of HLA-DR+ large granular lymphocytes in the induction of tumor necrosis factor by Mycobacterium avium-intracellulare complex.J Leukoc Biol. 1991 Dec;50(6):529-38. doi: 10.1002/jlb.50.6.529. J Leukoc Biol. 1991. PMID: 1682407
-
Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.J Immunol. 1988 Dec 1;141(11):4067-73. J Immunol. 1988. PMID: 2460557
Cited by
-
Biology of natural killer cells.Adv Immunol. 1989;47:187-376. doi: 10.1016/s0065-2776(08)60664-1. Adv Immunol. 1989. PMID: 2683611 Free PMC article. Review.
-
Monocyte-T-cell interactions in pokeweed mitogen-activated cultures.Immunology. 1990 Nov;71(3):397-403. Immunology. 1990. PMID: 1702749 Free PMC article.
-
Mycobacterium leprae renders Schwann cells and mononuclear phagocytes susceptible or resistant to killer cells.Infect Immun. 1991 Feb;59(2):684-8. doi: 10.1128/iai.59.2.684-688.1991. Infect Immun. 1991. PMID: 1898912 Free PMC article.
-
The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice.Acta Biochim Biophys Sin (Shanghai). 2016 Apr;48(4):385-90. doi: 10.1093/abbs/gmw010. Epub 2016 Feb 27. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 26922320 Free PMC article.
-
Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.J Clin Immunol. 1992 Jul;12(4):281-8. doi: 10.1007/BF00918152. J Clin Immunol. 1992. PMID: 1355096
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources